Astera Labs (ALAB) designs the silicon and software that keep data moving inside AI data centers — retimers, smart cable modules, memory controllers and Scorpio fabric switches that link accelerators across a rack. The stock traded at $200.29 shortly after Friday's opening bell, down $11.31 or 5.34%, against a prior close of $211.60. The direction is unambiguously lower: shares are now about 60% below their 52-week high of $499.48 and down roughly 24% over the past month. No company-specific press release, filing or analyst action explained the drop; the catalyst is a market-wide de-risking of AI infrastructure names.
The proximate driver is the unraveling of Thursday's AI euphoria. Anthropic's $81 billion listing — the largest IPO on record — opened 34% above its $83 offer price but closed up only 17%, and the shares fell roughly 10% in premarket trading Friday. Rather than lifting the sector, the deal pulled capital out of incumbent AI names. Thursday's session reversed from an early rally to a broad selloff: the S&P 500 lost 2%, its sixth straight decline, and the Nasdaq dropped 2.25%. Astera Labs, a high-beta supplier into hyperscaler capex budgets, is among the first names sold when conviction on AI spending weakens.
Rate expectations have turned decisively restrictive. Markets now assign roughly a 98% probability to a quarter-point hike at the December meeting after Philadelphia Fed President Anna Paulson said policy will need to tighten further, and the 10-year Treasury yield sits near 5.04%. That combination is punishing long-duration growth equities, and Astera Labs remains expensive on trailing metrics despite its retreat — a consequence of a multiple that had already priced in years of compounding rather than one quarter of execution.
Two further overhangs weighed on the group. Reports that TSMC and Samsung have halted some shipments to Chinese customers revived regulatory risk after the midterm elections, while SpaceX's $32 billion bond sale clearing at yields above 8% underscored how expensive debt-funded AI capacity has become. When the cost of financing data-center buildouts rises, the market marks down the entire supply chain — connectivity silicon included.
The move is sector-wide, not idiosyncratic. Friday's early tape showed CRDO down 5.8%, MRVL down 5.6%, NVDA down 3.4% and the SMH semiconductor ETF down 3.5%, versus losses of 1.2% for the Nasdaq 100 and 0.27% for the S&P 500. Coherent, Lumentum and Applied Optoelectronics each fell more than 5% premarket. Astera Labs is trading as a pure expression of AI capex sentiment, and the tape reflected that correlation.
Volume is running close to the stock's roughly 4.9 million-share daily average, with market capitalization near $35 billion — heavy participation, but no sign of a single forced seller. Thursday's session was the tell: shares spiked to $240.05 on an expanded Hyve Solutions partnership covering AI inference deployments, then slid to close at $211.60, a 12% intraday reversal that left overhead supply in place. Technically, the stock sits well below its 50-day and 200-day moving averages, both near $258–$270, and has broken below the $213 pivot that had contained the bounce attempt. With the broader index complex failing at its 200-day line and volatility above 30, dips are being sold rather than bought.
The score runs from 0, meaning no meaningful news and a move that is normal for the stock, to 100, meaning transformative news and an extreme, rare price move. For Astera Labs, the verified news is broad rather than company-specific: an AI-wide de-risking with no new disclosure from the company itself, worth only modest marks on materiality. The price move is similarly unremarkable by this stock's standards — just 1.2 times its typical absolute daily move of 4.4%, and 20 of the past 69 sessions produced an equal or larger swing. Those two factors combine to 15 out of 100.
Astera Labs reports fourth-quarter results in early February, with guidance of $730–$750 million in revenue and adjusted EPS of $1.62–$1.66 still the key reference point after a record $584.9 million third quarter. Before that, investors face next week's PCE inflation report and the December Fed decision, both capable of moving high-multiple semis more than any single product announcement. Analyst sentiment remains constructive on balance, with a Buy consensus and average targets far above the current quote — a spread that itself signals disagreement about how much upside is left. The risks are symmetric: a stabilization in AI capex sentiment would favor a rebound, while any hyperscaler commentary pointing to slower buildouts would extend the de-rating.
Tickeron's Trending AI Robots page curates the strongest performers from a library of hundreds of AI trading bots that cover thousands of tickers. Rather than listing the full catalog, it surfaces only the bots currently outperforming under live market conditions, letting traders see which strategies are working in a tape as volatile as this one. Bots differ widely by strategy, timeframe, performance metrics and the symbols they trade, so the page is a practical starting point for comparing approaches. Review the current leaders and see how they are positioned.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The 10-day moving average for ALAB crossed bearishly below the 50-day moving average on October 21, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 4 of 4 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
The Momentum Indicator moved below the 0 level on November 20, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ALAB as a result. In 37 of 46 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 80%.
The Moving Average Convergence Divergence Histogram (MACD) for ALAB turned negative on November 20, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 31 similar instances when the indicator turned negative. In 20 of the 31 cases the stock turned lower in the days that followed. This puts the odds of success at 65%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALAB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
The Aroon Indicator for ALAB entered a downward trend on November 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ALAB's RSI Oscillator exited the oversold zone, 11 of 14 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 79%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 22 of 28 cases where ALAB's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 79%.
Following a +7.12% 3-day Advance, the price is estimated to grow further. Considering data from situations where ALAB advanced for three days, in 148 of 167 cases, the price rose further within the following month. The odds of a continued upward trend are 89%.
ALAB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron SMR rating for this company is 37 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating steady price growth. ALAB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 77 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 88 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: ALAB's P/B Ratio (19.172) is very high in comparison to the industry average of (5.443). P/E Ratio (87.885) is within average values for comparable stocks, (15.640). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.803). Dividend Yield (0.000) settles around the average of (0.014) among similar stocks. P/S Ratio (40.650) is also within normal values, averaging (45.795).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALAB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry Semiconductors